Research & Studies
Share your love
Iridex 532 and Iridex 577 Lasers Introduced in the US
Iridex has launhed its latest laser platforms, the Iridex 532 and Iridex 577 lasers, in the United States. The company highlights that both lasers are equipped with multiple treatment modes, incorporating continuous-wave and the proprietary MicroPulse technology. The devices boast…
9 Steps on How to Administer Eye Drops Properly
Administering eye drops may seem like a simple task, but it is essential to get it right to ensure the effectiveness of the medication and avoid any potential complications. Whether you are treating dry eyes, allergies, or glaucoma, mastering the…
Belkin’s Eagle Device FDA Cleared for Laser Trabeculoplasty
Belkin Vision has received FDA 510(k) clearance for its Eagle device, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG laser developed for selective laser trabeculoplasty (SLT). The Eagle is positioned by Belkin as the first and only contactless laser for glaucoma, offering…
Keratoprosthesis: An Innovative Surgical Procedure
Keratoprosthesis refers to an innovative surgical procedure designed to restore vision in individuals suffering from severe corneal disease or damage. The term ‘keratoprosthesis’ is derived from the Greek words ‘kerato,’ meaning cornea, and ‘prosthesis,’ meaning artificial addition. The cornea, being…
FDA Warms 8 Companies for Unapproved Eye Items
On Monday, the US Food and Drug Administration (FDA) took action by sending warning letters to several companies, including CVS and Walgreens, due to concerns regarding the manufacturing and marketing of unapproved eye products. According to the FDA, these products…
Pioneering Glaucoma Therapy: $2M Research Grant Awarded
Researchers at Indiana University School of Medicine are embarking on a groundbreaking mission to develop a new therapy for glaucoma, a disease that can lead to blindness. This endeavor is made possible by a newly awarded five-year, $2 million R01…
Carl Zeiss Meditec to Acquire D.O.R.C.
Carl Zeiss Meditec AG announced that they have entered into an agreement to acquire 100% of the shares in D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. from Eurazeo SE, based in Paris, France. The deal is worth €985 million (nearly…
Sight Sciences Applauds Medicare’s MIGS Decision
Sight Sciences expressed its support for the decision made by five Medicare Administrative Contractors to withdraw their previously announced final local coverage determinations (LCDs) for Micro-Invasive Glaucoma Surgery, originally slated to become effective on January 29, 2024. The five MACs—WPS…
RevOpsis Raises $16.5M for Wet AMD Treatment
RevOpsis Therapeutics has announced the successful closure of its first seed funding round, securing a total of $16.5 million. This funding is set to advance the development and commercialization of treatments for chronic multifactorial diseases through the company’s innovative, fully…
Eye Exams May Track Neurodegeneration in Parkinson’s
Researchers from the University of the Basque Country (UPV/EHU) and Biobizkaia have explored the potential of using a common ophthalmological tool, optical coherence tomography, to monitor neurodegeneration in patients with Parkinson’s disease. This non-invasive method, commonly employed in eye health…